Mesothelioma Research News

Click the links below to view the Mesothelioma Lung Cancer Asbestos news article of your choice.


Radiotherapy doubles survival for patients with mesothelioma

Mon, 29 Apr 2019 12:54:37 EDT

Mesothelioma patients are twice as likely to survive for two years or longer, if they are treated with a high dose of radiation to the affected side of the trunk.

Mesothelin-targeted CAR T-cell therapy shows early promise in patients with solid tumors

Sun, 31 Mar 2019 19:25:35 EDT

A chimeric antigen receptor (CAR) T-cell therapy that targets the protein mesothelin showed no evidence of major toxicity and had antitumor activity in patients with malignant pleural disease from mesothelioma, according to new results.

Combination immunotherapy improves survival in mouse models of mesothelioma

Mon, 02 Apr 2018 14:24:58 EDT

Investigators have found that combined treatment with two cancer immunotherapy drugs -- one a novel immune modulator and one that focuses and activates the anti-tumor immune response -- significantly prolonged survival in mouse models of the aggressive cancer malignant mesothelioma.

Subset of carbon nanotubes poses cancer risk similar to asbestos in mice

Mon, 06 Nov 2017 13:20:18 EST

Researchers have shown for the first time in mice that long and thin nanomaterials called carbon nanotubes may have the same carcinogenic effect as asbestos: they can induce the formation of mesothelioma. The findings were observed in 10 percent -- 25 percent of the 32 animals included in the study, which has not yet been replicated in humans.

Loose-fill asbestos insulation and health

Thu, 02 Nov 2017 09:11:18 EDT

A landmark study into the health impacts of living in a house with loose-fill asbestos insulation.

Medical News Today

Pneumoconiosis: The risk of breathing in dust

Sun, 08 Oct 2017 09:00:00 PDT

Pneumoconiosis is a lung disease caused by dust particles. Symptoms include breathing difficulty and a cough. It can result from exposure to coal dust, asbestos particles, and cotton dust. It is considered an occupational risk. Complications include tuberculosis and respiratory failure. Employers may provide screening.

Rare genetic cause of peritoneal mesothelioma points to targeted therapy

Fri, 15 Sep 2017 06:00:00 PDT

Mesothelioma is a rare and aggressive tumor that, in many cases, results from exposure to asbestos.

Mesothelioma shows promising response to existing immunotherapy drug

Fri, 31 Mar 2017 07:00:00 PDT

Malignant pleural mesothelioma shows a promising response to treatment with the antibody drug pembrolizumab, which is used to treat other cancers.

Active agent from the Caribbean sea cucumber could improve treatment for malignant pleural mesothelioma

Tue, 25 Oct 2016 00:00:00 PDT

Researchers at the Comprehensive Cancer Center of MedUni Vienna and Vienna General Hospital have discovered a new option for treating malignant pleural mesothelioma.

Go to main Mesothelioma cancer resource page...